P Wiesli
Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
Köhler S, Tschopp O, Sze L, Neidert M, Bernays R, Spanaus K, Wiesli P, Schmid C. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?. Gen Comp Endocrinol 2013; 188:282-7.
May 4, 2013Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
May 4, 2013Gen Comp Endocrinol 2013; 188:282-7
Köhler S, Tschopp O, Sze Lisa, Neidert M, Bernays R-L, Spanaus K-S, Wiesli P, Schmid C
Excessively high soluble Klotho in patients with acromegaly
Sze L, Bernays R, Zwimpfer C, Wiesli P, Brändle M, Schmid C. Excessively high soluble Klotho in patients with acromegaly. J Intern Med 2012; 272:93-7.
Apr 23, 2012Excessively high soluble Klotho in patients with acromegaly
Apr 23, 2012J Intern Med 2012; 272:93-7
Sze Lisa, Bernays R L, Zwimpfer C, Wiesli P, Brändle Michael, Schmid C
Extensive spherical amyloid deposition presenting as a pituitary tumor
Wiesli P, Brändle M, Brandner S, Kollias S, Bernays R. Extensive spherical amyloid deposition presenting as a pituitary tumor. Journal of endocrinological investigation 2003; 26:552-5.
Jun 1, 2003Extensive spherical amyloid deposition presenting as a pituitary tumor
Jun 1, 2003Journal of endocrinological investigation 2003; 26:552-5
Wiesli P, Brändle Michael, Brandner S, Kollias S S, Bernays R L
A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
Wiesli P, Brändle M, Schwegler B, Lehmann R, Spinas G, Schmid C. A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. Journal of internal medicine 2002; 252:504-9.
Dec 1, 2002A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
Dec 1, 2002Journal of internal medicine 2002; 252:504-9
Wiesli P, Brändle Michael, Schwegler B, Lehmann R, Spinas G A, Schmid C